Enjoy complimentary customisation on priority with our Enterprise License!
The global kidney transplantation therapeutics market size is estimated to grow by USD 643.15 million, at a CAGR of 4.49% between 2023 and 2028.
The kidney transplantation therapeutics market has witnessed significant advances in surgical techniques and ancillary healthcare techniques in recent years. Such advances are increasing the demand for kidney transplantation. However, graft rejection is a major challenge associated with kidney transplantation. However, to overcome this challenge, vendors have developed immunosuppressants. Patients are required to undergo maintenance therapy using these immunosuppressants for the rest of their lives to reduce the risk and probability of the transplanted organ getting rejected by the body. Therefore, the increasing number of cases of kidney transplantation and the risks associated with transplant rejection are expected to fuel the demand for immunosuppressants, which will drive the growth of the market during the forecast period.
Technavio has segmented the market into Product, Distribution Channel, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.
To learn more about this report, Download Report Sample
The market share growth by the selective cytokine inhibitors segment will be significant during the forecast period. The segment involves the use of drugs that inhibit the production and function of cytokines. Cytokines are cell signaling molecules that help in mediating immune response signals from one cell to another and stimulate the movement of immune cells toward a foreign object. These immune cells include interleukins (ILs), interferons (IFNs), tumor necrosis factors (TNFs), colony-stimulating factors (CSFs), and transforming growth factors.
Get a glance at the market contribution of various segments Download PDF Sample
The selective cytokine inhibitors segment was valued at USD 1,039.94 million in 2018. Selective cytokine inhibitors have superior immunosuppressive activity compared with those belonging to other drug classes. Furthermore, the availability of tacrolimus in multiple dosage forms provides the option to adjust the dose as per a patient's needs. Due to these factors, the selective cytokine inhibitors segment of the global kidney transplantation market is expected to grow during the forecast period.
The distribution of kidney transplantation therapeutics through hospital pharmacies offers several benefits, contributing to the overall efficiency and effectiveness of the kidney transplantation process. Hospital pharmacies are often located within the hospital itself, making it easier for patients to obtain their medications after transplant surgery. In addition, hospital pharmacies can collaborate closely with transplant teams, fostering communication and coordination among healthcare providers. Hospital pharmacists often have specialized knowledge in transplant pharmacotherapy, ensuring that patients receive medications tailored to their specific needs. Hence, factors such as streamlined access to medication, reduced administrative burden, and improved communication and collaboration will boost the growth of the hospital pharmacy segment and promote market growth during the forecast period.
Retail pharmacies are often conveniently located, making it easier for transplant recipients to access their medications close to home. Retail pharmacies operate extended hours, including evenings and weekends. This extended accessibility ensures that patients can obtain their kidney transplantation medications outside of regular business hours, enhancing flexibility for those with busy schedules. Further, retail pharmacies are integrated with electronic health record systems, allowing seamless communication between healthcare providers and pharmacists. This integration supports better coordination of care, including medication adjustments and monitoring. Therefore, such factors will drive the growth of the retail pharmacy segment and promote market growth during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 45% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America has a significant prevalence of kidney diseases, including chronic kidney disease (CKD) and end-stage renal disease (ESRD). The rising incidence of these conditions contributes to an increased demand for kidney transplantation and associated therapeutics. The region benefits from advanced healthcare facilities, including state-of-the-art transplant centers, specialized nephrology units, and well-equipped hospitals.
Additionally, the pharmaceutical industry in North America is robust, with numerous companies actively engaged in the development and commercialization of drugs for kidney transplantation. The presence of key pharmaceutical players contributes to the availability of therapeutic options. Furthermore, the aging population in North America is more susceptible to kidney-related disorders. As the elderly population grows, the demand for kidney transplantation therapeutics is likely to increase, given the higher prevalence of kidney diseases in this demographic. Thus, such factors will drive the growth of the regional market during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
AbbVie Inc.: The company offers kidney transplantation therapeutics such as 2.0 Synopsis.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges.
The rising prevalence of CKD and renal impairments is the key factor driving market growth. Owing to the increasing number of cases of non-communicable diseases and their risk factors, the burden of CKD is increasing worldwide. CKD affects almost 8.5%-9.5% of the adult population globally. Diabetes, hypertension, vascular disease, and glomerulonephritis are some of the major causes of CKD. In most underdeveloped and developing countries, glomerulonephritis and interstitial nephritis are the two major causes of CKD, owing to the high prevalence of infections.
Furthermore, studies have revealed that CKD causes significant impairment of quality of life and decreases life expectancy at all ages. It is also associated with an increased risk of cardiovascular diseases, infections, diabetes, and cancer. Thus, the rising prevalence of CKD and renal impairments is expected to increase the need for kidney transplantation, which will drive the growth of the global kidney transplantation therapeutics market during the forecast period.
Increasing strategic alliances is the primary trend shaping market growth. The drug development process aligns with market trends and analysis requires a highly advanced R&D team, which most mid-sized and small pharmaceutical companies lack. Many small and mid-sized vendors do not achieve economies of scale, which affects their profits. To overcome these challenges, market players are entering into strategic alliances. For example, Veloxis Pharmaceuticals, the manufacturer of ENVARSUS XR, has a strong regional presence in Europe and an established distribution network in the US.
Similarly, the market also witnesses vendors getting into partnership agreements for the development of kidney transplantation therapeutics. For example, Roche and Aspreva Pharmaceuticals Corp. codeveloped CellCept, one of the most commonly used immunosuppressants for the prevention of kidney transplant rejection. Market players are also forming collaborations with academic institutions for the development of novel therapeutics. Thus, such factors are expected to drive market growth during the forecast period.
The demand-supply imbalance for kidney transplantation is a challenge that affects market growth. Although the incidence of kidney failure has been increasing significantly, owing to the rising prevalence of various renal indications, the market faces a threat from the shortage of kidneys to be transplanted. For instance, as per the National Kidney Foundation Inc. (National Kidney Foundation), CKD is prevalent in approximately 10% of the global population, and the mortality rate of the indication is increasing each year. The primary cause of death in patients with CKD is the lack of access to affordable treatment, including kidney transplantation.
The lack of kidneys available for transplantation is resulting in a surge in the number of patients on the waiting list, which is increasing the mortality rates among patients with kidney failure. Furthermore, despite the increasing number of awareness campaigns on organ donation, with a primary focus on kidney donation, to address the unmet need that currently exists, the market still witnesses a heavy gap between the need and the availability of kidneys. Thus, such factors will decline the growth of the market in focus during the forecast period.
The market report includes the adoption lifecycle of the market growth and forecasting, covering from the innovator’s stage to the laggard’s stage. The market analysis and report focus on adoption rates in different regions based on penetration. Furthermore, market research and growth report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Kidney Transplantation Therapeutics Market Customer Landscape
The kidney transplantation therapeutics market report forecasts market growth analysis by revenue at global, regional & country levels and provides an analysis of the latest market growth and trends from 2018 to 2028.
Kidney Transplantation Therapeutics Market Scope |
|
Report Coverage |
Details |
Page number |
171 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.49% |
Market Growth 2024-2028 |
USD 643.15 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.05 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 45% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
AbbVie Inc., Asahi Kasei Corp., Astellas Pharma Inc., B.Braun SE, Bristol Myers Squibb Co., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius Medical Care AG and Co. KGaA, GlaxoSmithKline Plc, Hansa Biopharma AB, Novartis AG, Organ Recovery Systems Inc., Pfizer Inc., Sanofi SA, Strides Pharma Science Ltd., TFF Pharmaceuticals Inc., TolerogenixX GmbH, TransMedics Inc., and Transonic Systems Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.